EW
Edwards Lifesciences Corporation
NYSE · USHealthcareMedical - Devices
$85.00-0.85%
Price as of Jul 20, 2026
EW valuation
Edwards Lifesciences Corporation valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 27.27x
- P/E 2026E
- 28.91x
- P/E 2027E
- 25.85x
- P/E 2028E
- 22.99x
- P/S forward
- 7.01x
Trailing multiples
- P/E TTM
- 44.97x
- PEG TTM
- 0.70x
- Price / book
- 4.74x
- Price / sales
- 7.76x
- Price / cash flow
- 36.02x
Enterprise value
- Enterprise value
- $46.0B
- EV / sales
- 7.29x
- EV / EBITDA
- 32.36x
- EV / EBIT
- 26.41x
- Market cap
- $48.9B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.